×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [35]
内容类型
期刊论文 [33]
会议论文 [2]
发表日期
2019 [10]
2018 [4]
2017 [7]
2016 [6]
2015 [4]
2014 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共35条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:
Liang Hongge
;
Ma Di
;
Xu Yan
;
Zhao Jing
;
Chen Minjiang
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/01/03
crizotinib
echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase
lactate dehydrogenase
non-small cell lung cancer
progression-free survival
Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE,
期刊论文
2019, 卷号: 42, 期号: 5, 页码: 432-439
作者:
Song, Yong
;
Wu, Yi-Long
;
Cao, Le-Jie
;
Chen, Jian-Hua
;
Ma, Zhi-Yong
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/01/03
re-challenge
gefitinib
T790M mutation
progression-free survival
EGFR-TKI
NSCLC
Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis
期刊论文
2019, 卷号: 15, 期号: 20, 页码: 2413-2422
作者:
Jing, Shao-wu
;
Qin, Jian-jun
;
Liu, Qing
;
Zhai, Chang
;
Wu, Ya-jing
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
chemoradiotherapy
chemotherapy
complication
esophageal neoplasms
meta-analysis
neoadjuvant
overall survival
pathological complete regression
progression-free survival
R0 resection rate
PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population
期刊论文
2019, 卷号: 45, 期号: 3, 页码: 353-358
作者:
Bi, Yalan
;
Ren, Xinyu
;
Bai, Xiaohui
;
Meng, Yunxiao
;
Luo, Yufeng
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Medullary thyroid carcinoma (MTC)
Programmed cell death protein 1 (PD-1)
Programmed death-ligand 1 (PD-L1)
Distant metastasis at surgery
Progression free survival
Overall survival
High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery
期刊论文
2019, 卷号: 85, 页码: 101-111
作者:
Ban, Xinchao
;
Yan, Jie
;
Yu, Shuangni
;
Lu, Zhaohui
;
Chang, Xiaoyan
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/01/03
Pancreatic neuroendocrine neoplasms
Minichromosome maintenance protein 7
Ki-67
Progression-free survival
Proliferation index
Clinicopathological Characteristics, Surgical Treatments, and Survival Outcomes of Patients with Duodenal Gastrointestinal Stromal Tumor
期刊论文
2019, 卷号: 36, 期号: 3, 页码: 206-217
作者:
Zhang, Shuisheng
;
Tian, Yuan
;
Chen, Yingtai
;
Zhang, Jianwei
;
Zheng, Cuiling
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
Duodenal gastrointestinal stromal tumor
Pancreaticoduodenectomy
Limited resection
Overall survival
Progression-free survival
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
期刊论文
2019, 卷号: 15, 期号: 1, 页码: 3267-3278
作者:
Sheng, Xinan
;
Bi, Feng
;
Ren, Xiubao
;
Cheng, Ying
;
Wang, Jinwan
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Asian patients
axitinib
progression-free survival
renal cell carcinoma
A cohort study of hypersensitivity reaction in patients with epithelial ovarian cancer treated with carboplatin
期刊论文
2019, 卷号: 29, 期号: 3, 页码: 566-571
作者:
Sun, Tingting
;
Li, Lei
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2020/01/03
adverse events
carboplatin
epithelial ovarian cancer
hypersensitivity reaction
progression-free survival
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:
Huang, Jing
;
Xu, Binghe
;
Liu, Ying
;
Huang, Junxing
;
Lu, Ping
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/01/03
Esophageal squamous cell carcinoma
Recurrent
Metastasis
Multicenter
open-label
randomized trial
Irinotecan
S-1
Overall survival
Progression-free survival
Objective response rate
Disease control rate
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
期刊论文
2019, 卷号: 112, 页码: 57-65
作者:
Yuan, Peng
;
Hu, Xichun
;
Sun, Tao
;
Li, Wei
;
Zhang, Qingyuan
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/01/03
Progression-free survival
Tolerability
Locally recurrent or metastatic breast cancer
Eribulin
©版权所有 ©2017 CSpace - Powered by
CSpace